Evidence map›Paper›PMID 42063257›Full record

ArticleHGG advances2026

Biallelic loss-of-function variants in DSCAM cause a neurodevelopmental syndrome with nystagmus and retinal dysfunction.

Sofia Douzgou Houge, Cecilie Bredrup, Ragnhild Wivestad Jansson, Ognjen Bojovic, Bayan M Aljamal, Maha Al-Otaibi, Astrid S Plomp, Mahdi M Motazacker, Maria M van Genderen, Anne Mellgren and 5 more

Abstract readCase Reports
In one paragraph

Article in HGG advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sofia Douzgou HougeDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway; Frambu Unit, Norwegian Centre for Rare Diseases, Siggerud, Norway; Brain Disorders Unit, Norwegian Centre for Rare Diseases, Oslo, Norway.
Cecilie BredrupDepartment of Ophthalmology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway.
Ragnhild Wivestad JanssonDepartment of Ophthalmology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway.
Ognjen BojovicDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Bayan M AljamalDepartment of Translational Genomics, Centre for Genomic Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Maha Al-OtaibiDepartment of Genetics, King Saud Medical City, Riyadh, Saudi Arabia.
Astrid S PlompDepartment of Human Genetics, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Mahdi M MotazackerDepartment of Human Genetics, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Maria M van GenderenBartiméus Diagnostic Center for Complex Visual Disorders, Zeist, the Netherlands; Department of Ophthalmology, University Medical Center Utrecht, Utrecht, the Netherlands.
Anne MellgrenDepartment of Ophthalmology, Haukeland University Hospital, Bergen, Norway.
Hisham AlkurayaGlobal Eye Care, Specialized Medical Center Hospital, Riyadh, Saudi Arabia.
Omar HikmatDepartment of Pediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science (K2), University of Bergen, Bergen, Norway.
Bjørn Ivar HaukanesDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Fowzan S AlkurayaDepartment of Translational Genomics, Centre for Genomic Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; Lifera Omics, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Gunnar Douzgos HougeDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science (K2), University of Bergen, Bergen, Norway; Western Norway Precision Medicine Centre (NorPrem-HV), Haukeland University Hospital, Bergen, Norway. Electronic address: gunnar.douzgos.houge@helse-bergen.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DSCAM occupies a 1-Mb locus in the original Down syndrome critical region on chromosome 21q22 and encodes a neuronal cell adhesion molecule of importance for brain and eye development. Singleton individuals, both born to first-cousin parents, with intellectual disability and homozygous DSCAM loss-of-function variants were reported in 2017 and in 2021, the latter also presenting with nystagmus and visual impairment. We present a cohort of five individuals, four new, including two sibling pairs with homozygosity or compound heterozygosity for predicted loss-of-function DSCAM variants. We identify a common clinical pattern of moderate to severe neurodevelopmental delay with poor language development, risk of focal seizures with onset in infancy, and nystagmus with poor vision. Electroretinography in two of the affected revealed cone-pathway dysfunction with a b-wave pattern indicating main dysfunction at the level of the cone-associated bipolar cells of the central retina. Our electroclinical findings are in line with previous DSCAM knockout chicken and mice studies that evidenced disturbed horizontal and vertical patterning of the retina. Taken together, we delineate a rare syndromic form of recessive intellectual disability with a distinctive type of visual impairment.

Indexed as

AllelesCell Adhesion MoleculesLoss of Function MutationNeurodevelopmental DisordersNystagmus, PathologicRetinal DiseasesAdolescentChildElectroretinographyFemaleHumansInfantMalePedigreeCell Adhesion MoleculesDSCAM protein, humanbipolar cellscone dysfunctionDSCAMneurodevelopmental delaynystagmusseizures

Identifiers

PMID42063257
PMCPMC13199882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.